Kindred Biosciences

About:

Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.

Website: http://www.kindredbio.com

Twitter/X: KindredBio

Top Investors: SLR Capital Partners, General American Investors Company,Inc

Description:

Kindred Biosciences is a veterinary biotechnology company, focuses on developing therapies for dogs, cats, and horses. It develops canine, feline, and equine antibodies for the treatment of diseases in companion animals. Its strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. Their mission is to bring innovative biologics to veterinary medicine because they believe their pets deserve the same kinds of safe and effective medicines that human family members enjoy. The company was incorporated in 2012 and is based in San Francisco, California.

Total Funding Amount:

$62.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Burlingame, California, United States

Founded Date:

2012-01-01

Contact Email:

customerservice(AT)kindredbio.com

Founders:

Denise Bevers, Richard Chin

Number of Employees:

51-100

Last Funding Date:

2019-10-02

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai